Feb 6

In the lead up to going in to the CDK4/6 study we had to repeat Joshua’s MRI, and do new baseline bloodworm etc. The study should start next Monday. This drug is supposed to replace the inhibitor he is missing and to slow/stop cell regeneration.

The new MRI wasn’t as good as hoped, but better than expected. Odd I know. But with the increase in symptoms, I was sure the Avastin was hiding a lot more than suggested to us to expect in this MRI. But more tumor, more perfusion into the center brain from the original tumor bed, more growth at the ventricles and a new spot in the cerebellum.